Medical/Pharmaceuticals

Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China

* First glucokinase-activator (GKA) approval outside mainland China * Approval supports a differentiated approach to Type 2 diabetes (T2D) management * Hong Kong will serve as Hua Medicine's launchpad for international market expansion SHANGHAI and HONG KONG, March 3, 2026 /PRNewswire/ -- Hu...

2026-03-03 13:58 13250

/C O R R E C T I O N -- CooperVision, Inc./

In the news release, CooperVision Expands MyDay® MiSight® 1 day Myopia Control Soft Contact Lenses Into Asia Pacific Region, issued 02-Mar-2026 by CooperVision, Inc. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with addition...

2026-03-03 10:27 8686

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

NEW YORK, March 3, 2026 /PRNewswire/ -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty business in Asia. Ken joins Royalty Pharma from Morgan St...

2026-03-03 10:15 6133

Bright Eye Clinic Achieves Government Accreditation Amid Korea's Medical Tourism Growth

SEOUL, South Korea, March 3, 2026 /PRNewswire/ -- Bright Eye Clinic announced its official accreditation under theKorean Accreditation Program for Hospitals Serving Foreign Patients (KAHF), administered by the Korea Health Industry Development Institute (KHIDI) ...

2026-03-03 10:00 4241

AsiaMedic Delivers Improved FY2025 Performance as Core Imaging Business Strengthens

* Financial performance strengthened alongside business expansion as newly added capacity are ramped up during the year * Profit attributable to owners of the Company doubled to S$2.0 million in FY2025 * Disposal of 60% interest in aesthetic business sharpens focus on core healthcare operat...

2026-03-03 09:40 6113

Efor strengthens its presence in Asia with the acquisition of No deviation

LYON, France, March 3, 2026 /PRNewswire/ -- Efor, a global leader specializing in quality and compliance for the Life Sciences industry, announces the acquisition of Singapore-based No deviation, a company recognized for its expertise in Commissioning, Qualification & Validation (CQV), Computer S...

2026-03-03 09:00 6602

US BioTek Laboratories Completes Merger With NutriPATH Pathology

SEATTLE and MELBOURNE, Australia, March 3, 2026 /PRNewswire/ -- US BioTek Laboratories, a leading functional laboratory specializing in advanced immunological and integrative diagnostics, today announced the completion of its merger with NutriPATH Pathology, a respected functional pathology labo...

2026-03-03 02:15 5904

Skyhawk Announces Australia's Therapeutic Goods Administration Has Determined SKY-0515 for Huntington's Disease Meets Eligibility Criteria for Registration via the Provisional Approval Pathway

Australia's Therapeutic Goods Administration (TGA), responsible for approval of the safety, quality, and efficacy of therapeutic goods, has determined that Skyhawk's SKY-0515 orally-administered small molecule therapy for the treatment of Huntington's disease meets TGA eligibility criteria for re...

2026-03-03 01:20 5459

The Sigourney Award-2026 Now Accepting Applications for Psychoanalytic Innovation

International Prize Honors Trailblazing Work Advancing Psychoanalytic Thought and Principles — Cash Award and Global Recognition SAN FRANCISCO, March 2, 2026 /PRNewswire/ -- The Sigourney Award Trust welcomes applications for The Sigourney Award-2026 from individuals, teams, and organizations wo...

2026-03-02 22:49 4000

Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit

LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing therapies grounded in human biology, today announced that it will deliver a company presentation at the BIO Investment & Growth Summit. David Bearss, Ph.D., Chief Executive Officer ...

2026-03-02 21:35 4155

The largest pharma show in Asia makes its return to Shanghai this June 2026

SHANGHAI, March 2, 2026 /PRNewswire/ -- CPHI & PMEC China 2026 is set to take place from16 to 18 June 2026 at the Shanghai New International Expo Centre (SNIEC), building on its extremely successful run over the last few years. CPH...

2026-03-02 20:09 6274

ECR 2026: Esaote Group Introduces Breakthroughs in Ultrasound, MRI and Enterprise Imaging

The new MyLab™E85 GTS and MyLab™C30 GTS Edition ultrasound systems will be presentedon Thursday, 5th March at 11.30 a.m. at the Esaote Booth GENOA, Italy, March 2, 2026 /PRNewswire/ -- Esaote Group, a leading Italian innovator in medical imaging – ultrasound, dedicated magnetic resonance and med...

2026-03-02 19:30 6164

COLUMBIA ASIA HOSPITAL BUKIT JALIL LAUNCHES NEW CATH LAB TO STRENGTHEN HEART CARE SERVICES

The new cardiac catheterisation facility enables faster, minimally invasive treatment and improved access to specialist care, closer to home. KUALA LUMPUR, Malaysia, March 2, 2026 /PRNewswire/ -- Columbia Asia Hospital Bukit Jalil has officially launched its new Cardiac Catheterisation Laboratory...

2026-03-02 14:24 13380

XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication

- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with multiple myeloma (MM). - In South Korea, XPOVIO® has been approved for three indications across MM and diffuse large B-cell lymphoma...

2026-03-02 08:30 6364

Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis

SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced positive topline results from its Phase III ...

2026-03-02 08:00 8251

Investor Education Webinar

The Future of Prostate Imaging: What do physicians want? MELBOURNE, Australia and INDIANAPOLIS, March 2, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") invites investors to join a webinar with key opinion leaders to discuss a physician's perspective on innova...

2026-03-02 06:56 4621

Prof. Mike Chan and Leigh Steinberg Launch "Concussion" Book at Super Bowl Brain Health Summit 2026

SAN FRANCISCO, Feb. 27, 2026 /PRNewswire/ -- European Wellness Biomedical Group, through its education division European Wellness Academy, is pleased to announce the official launch of "Concussion: The Hidden Trauma in Contact Sports and the NFL," co-authored by legendary NFL sports agent Leigh S...

2026-02-27 18:04 6079

ASEAN Foundation introduced CALM MRI: Children and the No Longer Scary Machine

SINGAPORE, Feb. 27, 2026 /PRNewswire/ -- The ASEAN Foundation organized the regional programme"CALM MRI – Fear to Confidence: Learning through Play with LEGO MRI Kits Programme", implemented across Indonesia and Singapore. The initiative serves as a platform to present the programme's outcomes, w...

2026-02-27 12:39 4300

Basecare Medical (HK.2170) Receives NMPA Approval for Core Product Geri Medium, Unlocking New Opportunities in Assisted Reproduction

SUZHOU, China, Feb. 27, 2026 /PRNewswire/ -- Basecare Medical (02170.HK) has recently encountered a key catalyst——its Gems one-step embryo culture medium has officially obtained the China Class III Medical Device Registration Certificate (National Medical Products Administration Registration No. ...

2026-02-27 10:49 9124

Cynosure Lutronic bolsters its strength in APAC -- The world's fastest-growing medical aesthetics device region, with dual regulatory approvals for the Clarity II™ in China and Japan, February 2026

SINGAPORE, Feb. 27, 2026 /PRNewswire/ -- Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and Japan. This marks a significant expansion of the com...

2026-02-27 10:33 9732
1 ... 32333435363738 ... 385

Week's Top Stories